EA and WPDL Updates 1/19/16

 

HCA Apple Health Medicaid

 


Provider Alert

                                                                   

Dear Provider,

Effective for claims with dates of service on and after January 19, 2016, Washington Apple Health (Medicaid), administered by the Health Care Authority (the agency) will update the Expedited Authorization (EA) list and Washington Preferred Drug List (WPDL) as follows:

Expedited Authorization List

Drug Class

Drug Name

Change

NSAIDs

All medications in drug class

Removal of EA requirement

 

Washington Preferred Drug List

Drug Class

Drug Name

Preferred Status

Long-Acting Anticholinergics

Seebri Neohaler®

Non-preferred, not subject to DAW-1 override/ TIP

Long-Acting Beta-Agonist Combinations

Utibron Neohaler®

Non-preferred, not subject to DAW-1 override/ TIP

Long-Acting Opioids

Belbuca®

Non-preferred, not subject to DAW-1 override

NSAIDS

Vivlodex®

Non-preferred

 

For more details, see the agency’s Prescription Drug Program Provider Guide page for the current EA list and WPDL.